Roivant Sciences (ROIV) Gross Margin (QoQ) (2020 - 2025)
Powered by 
Analysis
Roivant Sciences (ROIV) Gross Margin (QoQ) (2020 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.56 Bn | 197.57 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 181.34 Bn | 178.16 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.22 Bn | 124.37 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.87 Bn | 74.88 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.55 Bn | 56.37 Bn | 1.37 Bn |
| 6 | Moderna | 54.32 Bn | 49.19 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.32 Bn | 31.01 Bn | 992.69 Mn |
| 8 | Biogen | 31.24 Bn | 29.95 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.17 Bn | 30.17 Bn | 1.16 Mn |
| 10 | Insmed | 28.17 Bn | 27.01 Bn | 358.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -975.00 |
| Sep 30, 2025 | 3.00 |
| Dec 31, 2024 | 194.00 |
| Sep 30, 2024 | -256.00 |
| Dec 31, 2023 | 19.00 |
| Sep 30, 2023 | 1,337.00 |
| Dec 31, 2022 | 264.00 |
| Sep 30, 2022 | 1,091.00 |
| Dec 31, 2021 | 2,715.00 |
| Sep 30, 2021 | -3,603.00 |
| Dec 31, 2020 | 4,215.00 |
| Sep 30, 2020 | -4,262.00 |